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Abstract In recent years, there has been an increasing interest
in the exploitation of microalgae in industrial biotechnology.
Potentially, these phototrophic eukaryotes could be used for
the low-cost synthesis of valuable recombinant products such
as bioactive metabolites and therapeutic proteins. The algal
chloroplast in particular represents an attractive target for such
genetic engineering, both because it houses major metabolic
pathways and because foreign genes can be targeted to specif-
ic loci within the chloroplast genome, resulting in high-level,
stable expression. However, routine methods for chloroplast
genetic engineering are currently available only for one spe-
cies—Chlamydomonas reinhardtii—and even here, there are
limitations to the existing technology, including the need for
an expensive biolistic device for DNA delivery, the lack of
robust expression vectors, and the undesirable use of antibiot-
ic resistance markers. Here, we describe a new strain and
vectors for targeted insertion of transgenes into a neutral chlo-
roplast locus that (i) allow scar-less fusion of a transgenic
coding sequence to the promoter/5′UTR element of the highly
expressed endogenous genes psaA or atpA, (ii) employ the
endogenous gene psbH as an effective but benign selectable
marker, and (iii) ensure the successful integration of the trans-
gene construct in all transformant lines. Transformation is
achieved by a simple and cheap method of agitation of a
DNA/cell suspension with glass beads, with selection based
on the phototrophic rescue of a cell wall-deficient ΔpsbH
strain. We demonstrate the utility of these tools in the creation
of a transgenic line that produces high levels of functional
human growth hormone.
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Introduction
Microalgae represent attractive biotechnology platforms for
the synthesis of recombinant therapeutic proteins and other
high-value products (Gong et al. 2011; Rasala and Mayfield
2015). Key advantages when compared to one or more of the
traditional heterotrophic platforms such as Escherichia coli,
yeast, or CHO cells include (i) the low-cost phototrophic cul-
tivation of the alga in sterile, controlled photobioreactors
using simple and inexpensive medium; (ii) the generally rec-
ognized as safe (GRAS) status of a number of algal species
including the chlorophyte Chlamydomonas reinhardtii, mak-
ing possible the oral delivery of bioactive products in whole
algae and therefore avoiding expensive downstream purifica-
tion; and (iii) the chloroplast organelle as a unique biosynthet-
ic and storage compartment that contains its own minimal
genetic system. Importantly, the use of the chloroplast for
expression of foreign genes rather than the algal nucleus con-
fers several benefits including precise insertion into the chlo-
roplast genome (or “plastome”) via homologous recombina-
tion, high-level expression that is not subject to any gene-
silencing mechanisms, the possibility of expressing multiple
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transgenes as operons, and accumulation of the recombinant
proteins in a benign compartment where the formation of di-
sulfide bonds occurs readily (Tran et al. 2009) but undesirable
glycosylations are avoided (Gregory et al. 2013).
Chloroplast transgenics were first reported in 1991 when a
bacterial antibiotic-resistance gene was expressed in
C. reinhardtii (Goldschmidt-Clermont 1991). Since that time,
there have been many reports describing the synthesis of func-
tional therapeutic proteins in the C. reinhardtii chloroplast in-
cludingmonoclonal antibodies (Mayfield et al. 2003; Tran et al.
2009), growth factors (Rasala et al. 2010), antigens (Dreesen
et al. 2010; Michelet et al. 2011; Jones et al. 2013), gut-active
proteins (Manuell et al. 2007; Yoon et al. 2011), anti-bacterial
proteins (Braun-Galleani et al. 2015), immunotoxins (Tran
et al. 2013a, 2013b), and anti-toxins (Barrera et al. 2015). In
addition, efforts are being made to manipulate chloroplast bio-
synthetic pathways in order to synthesize novel bioactive com-
pounds such as diterpenoids (Gangl et al. 2015; Zedler et al.
2015). This encouraging progress in the development of the
algal chloroplast as a viable platform has recently led to the
establishment of start-up companies seeking to exploit the tech-
nology and the demonstration of pilot-scale production of a
bioactive protein (Gimpel et al. 2015).
However, there remains a need to develop improved mo-
lecular tools that address some of the current technical limita-
tions in the generation of C. reinhardtii transgenic lines
(Purton et al. 2013). Specifically, there is a need for a simple
and reliable method of rapidly generating homoplasmic
transformant lines that also avoids the use of bacterial
antibiotic-resistance genes as selectable markers. Currently,
transformation typically involves bombardment of an algal
lawn with DNA-coated microparticles (= biolistics) and the
use of the aadA or aphA6 bacterial genes as selectablemarkers
conferring resistance to spectinomycin and kanamycin, re-
spectively (Goldschmidt-Clermont 1991; Bateman and
Purton 2000). Resistant colonies are then checked for the
presence of the gene of interest (GOI) and taken through mul-
tiple rounds of single-colony selection in order to ensure that
the transformant lines attain a stable, homoplasmic state in
which all copies of the polyploid genome contain the marker
and the GOI. A simpler alternative to microparticle bombard-
ment involves agitating a suspension of cells and transforming
DNA in the presence of glass beads, although this method
requires the prior removal of the cell wall either by digestion
or mutation (Kindle et al. 1991; Economou et al. 2014).
Similarly, one alternative method for selection employs
non-photosynthetic mutants as recipient strains where the
genetic lesion is in a key photosynthetic gene on the chlo-
roplast genome. Selection is based on the use of a wild-
type copy of the gene as the marker with successfully
transformed cells able to grow phototrophically on mini-
mal medium through replacement of the mutated gene
with the wild-type version (Purton 2007; Michelet et al.
2011; Chen and Melis 2013). This selection strategy
therefore allows the introduction of a GOI as the only
transgene, avoiding the use of any antibiotic-resistance
gene. Such “marker-free” transgenic lines are appropriate
for industrial cultivation since they circumvent the regu-
latory and environmental issues associated with the pos-
sible horizontal transfer of such resistance genes into oth-
er microorganisms. Other issues associated with
antibiotic-based selection include (i) the occurrence of
“false-positive” colonies due to natural resistance muta-
tions arising in C. reinhardtii genes, (ii) the additional
metabolic burden on the chloroplast of replicating and
expressing the marker, and (iii) the challenge of using
antibiotic selection to drive transformant lines efficiently
to a homoplasmic state.
Our recent work on C. reinhardtii chloroplast engineering
(Braun-Galleani et al. 2015; Young and Purton 2014, 2016)
has involved the use of a new recipient strain and expression
vectors that allow the generation of marker-free transformants
using the glass bead transformation method. In this paper, we
describe these tools in detail. The recipient strain carries the
nuclear cw15 mutation resulting in a cell wall-deficient phe-
notype, together with a deletion of the essential photosystem II
gene psbH to allow selection based on phototrophy. The ex-
pression vectors carry the psbH marker and are designed to
allow simple cloning of a GOI as a perfect translational fusion
with the promoter and 5′ untranslated region (UTR) from var-
ious chloroplast genes. We find that the vector that uses the
psaA promoter/5′UTR element gives high expression levels in
the chloroplast and is able to serve as a dual expression vector,
since expression is also readily detectable in E. coli. Finally,
we describe a simple three-primer PCR strategy to confirm
both the correct integration of the GOI into the plastome and
the establishment of homoplasmy. To validate these new tools,
we have created a transgenic line expressing a synthetic gene
encoding human growth hormone (hGH) and shown that the
hGH is biologically active.
Materials and methods
C. reinhardtii strains and culture conditions The TN72
strain is a psbH::aadA knockout mutant of the cell wall-
deficient strain cw15.mt+ (Davies and Plaskitt 1971) and
was created as described below. TN72 has been deposited in
the publicly available collection of the Chlamydomonas
Resource Center (chlamycollection.org) as strain CC-5168.
TN72 transformant lines were initially selected on 2 % agar
plates containing high salt minimal (HSM) medium but then
maintained on Tris-acetate phosphate (TAP) agar plates
(Harris et al. 2009) under dim light (5–10 μE/m2/s) at 20 °C.
For liquid cultures, cells were grown in TAP medium in con-
ical flasks at 25 °C, 120 rpm at 5 μE/m2/s (for TN72) or
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50 μE/m2/s (for transformants). Spectinomycin (100 μg/ml)
and erythromycin (10–50 μg/ml) were added to TAP agar
medium as required.
Plasmid construction DNA manipulations were carried out
using standard protocols (Green and Sambrook 2012), in-
cluding transformation of chemically competent E. coli
DH5α using ampicillin selection. Oligonucleotide primers
were obtained from Eurofins Genomics (Ebersberg,
Germany); restriction enzymes and T4 DNA ligase for clon-
ing procedures were purchased from NEB (Ipswich, MA,
USA) and Thermo Scientific (Waltham, MA, USA). Details
of oligonucleotide primers used for plasmid construction
are given in Table S1. Plasmid p72B-aadA-BM, which
was used to create TN72, was made by replacing the 0.36-
kb MluI-BstXI region of p72B (Bateman and Purton 2000)
with the “aadA cassette” (comprising the aadA coding se-
quence fused to the atpA promoter/5′UTR and rbcL 3′UTR)
amplified from pUC-atpX-AAD (Goldschmidt-Clermont
1991) using primers that introduced an MluI and BstXI site
at the ends of the cassette. Transformation vector pASapI
was created from p72B-SH (Bateman and Purton 2000), by
first cutting p72B-SH with SapI (within the pUC8 vector)
and EcoRI, end-filling, and religating, thereby removing a
240-bp region of the vector sequence including the unwant-
ed SapI site. Then, the MluI-NcoI region containing the
rbcL promoter/5′UTR element was replaced with an equiv-
alent region amplified from atpA to give pASapI in which a
SapI site was created immediately downstream of the start
codon. Vectors pSRSapI, pPSapI, and pCSapI were created
from pASapI by replacing the MluI to SapI region of
pASapI with the promoter/5′UTR region of psaA exon 1,
psbA, and chlL, respectively. The sequences of pASapI and
pSRSapI are given in Fig. S1. The ereB coding sequence
was amplified from plasmid pAT72 (Arthur and Courvalin
1986) using primers that introduce an NcoI and SphI site at
the start and end of the coding region, respectively, and
cloned into these sites in pSRSapI to create pRY129a. The
synthetic gene for hGH was codon-optimized for the
C. reinhardtii chloroplast using the Codon Usage
Database (www.kazusa.or.jp/codon) with SapI and SphI
s i tes added for cloning (Fig. S2) . The gene was
synthesized by Life Technologies (Carlsbad, CA, USA)
and cloned into the four expression vectors.
Chloroplast transformation Chloroplast transformation
was based on a previously described method (Kindle
et al. 1991) and involved the agitation of an algal/DNA
suspension with glass beads of 400–625 μm diameter. A
400-ml culture grown to early log phase (approx.
2 × 106 cells/ml) was concentrated by centrifugation and
resuspended in TAP medium to 4 ml. Three hundred mi-
croliters of cells were added to a sterilized 5-ml test tube
containing 300 mg sterile glass beads, followed by 5–
10 μg circular plasmid DNA. The mixture was agitated
vigorously at the maximum speed of a Vortex Genie II
(Fisher Scientific, Loughborough, UK) for 15 s. The cells
were spread on selective agar plates (TAP + spectinomy-
cin at 100 μg/ml for aadA selection; HSM for psbH se-
lection) after mixing with 0.5 % molten (42 °C) agar of
the same selective medium. The plates were incubated at
25 °C in dim light (~2 μE/m2/s) overnight then transferred
to a moderate light (~50 μE/m2/s) the next day.
Transformant colonies were picked after 2–3 weeks and
restreaked to single colonies several times on selective
media to ensure homoplasmicity, although this was often
achieved after the first streaking. Homoplasmy was deter-
mined by PCR using a combination of three primers
(Table S1). Total genomic DNA was extracted from a
loopful of cells using the Chelex 100 method as described
by Werner and Mergenhagen (1998), and PCR amplifica-
tion was carried out with Phusion DNA polymerase
(Thermo Scientific) according to the manufacturer’s in-
structions. The photosystem II-deficient phenotype of
TN72 was confirmed by measuring the photosynthetic
capacity through chlorophyll fluorescence (Maxwell and
Johnson 2000). Putative transformant lines were spotted
onto TAP agar plates, incubated for 5 days and scanned
using a pulse-modulated imaging fluorometer (FluorCam
700MF, Photon Systems Instruments, Czech Republic) as
described by Wingler et al. (2004).
Western analysis of C. reinhardti i and E. coli
transformants Protein samples from C. reinhardtii were
prepared, fractionated on a 15 % acrylamide SDS-PAGE
gel and blotted onto nitrocellulose membrane as described
by Young and Purton (2014). For immunodetection, mem-
branes were blocked in TBS-T (20 mM Tris, 137 mM
NaCl, 1 M HCl pH 7.4, 0.1 % Tween-20) with 0.5 % milk
powder overnight at 4 °C. Membranes were incubated
with primary antibody in TBS-T with 0.5 % milk (1 h at
RT), washed 3 × 5 min in TBS-T, incubated with second-
ary antibody in TBS-T with 0.5 % milk (1 h at RT), and
washed as before. The probed blots were scanned and
quantified using an Odyssey Infrared Imaging System
(LI-COR). Alternatively, for Fig. 5a, the antibody binding
was detected by enhanced chemiluminescence (ECL)
using SuperSignal West Pico Chemiluminescent substrate
(Thermo Scientific) and Hyperfilm ECL (GE Healthcare).
For hGH detection, the primary antibody was chicken
polyclonal antibody to human growth hormone (Abcam
product ab27223) at 1:5000 dilution and the secondary
was donkey anti-chicken IgY IRDye 800CW (LI-COR)
at 1:5000, or goat anti-chicken IgY HRP-linked antibody
(Abcam product ab97135) at 1:5000 for ECL. For RbcL
detection, the primary antibody was anti-RbcL produced
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in rabbit (a gift from John Gray, Cambridge University,
UK) at 1:5000 followed by secondary antibody Goat anti-
Rabbit IgG (H&L), Dylight™ 800 Conjugated (Thermo
Scientific product 35571) at 1:10,000, or HRP-linked
Goat Anti-Rabbit IgG H&L (Abcam product ab6721) at
1:5000 for ECL.
For the detection of proteins in E. coli, 5 ml of an overnight
LB culture was harvested by centrifugation (10 min at 4500 g)
and resuspended inX/4 ml solution A (0.8M Tris-HCl pH 8.3,
0.2 M sorbitol, 1 % β-mercaptoethanol) where X is the absor-
bance of the culture at 600 nm. SDS was added to a final
concentration of 1 %. Samples were boiled for 5 min and
passed through a 0.5-mm needle then centrifuged (2 min at
21,000 g), and 25 μl of supernatant was loaded. Gel and hGH
immunodetection conditions using the ODYSSEY system
were as described above. For both the Chlamydomonas and
E. coli analysis, pure recombinant hGH (Abcam product
51232) was used as a reference.
Nb2-11 cell proliferation assay for hGH activity Nb2-11
cells (European Collection of Cell Cultures) were grown in
suspension culture in Fischer’s medium supplemented with
10 % fetal bovine serum, 10 % horse serum, 2 mM L-gluta-
mine, 0.075 % sodium bicarbonate, and 0.05 mM β-
mercaptoethanol, at 37 °C in an atmosphere containing 5 %
CO2. Cells were starved for 24 h by centrifugation (750 g for
5 min) to remove the culture medium, followed by washing
and resuspending the cells in supplemented Fischer’s medium
excluding fetal bovine serum. The cells were seeded in a 12-
well plate at a concentration of approximately 1 × 105 cells/
ml. Recombinant hGH (Abcam) was added to 1 ml of cells in
a volume of 5 μl to give a final concentration of 1, 10, or
100 ng/ml. Phosphate buffer (50 mM, pH 7.4) was added to
cells as a control and was used to dilute the hGH. Samples
were analyzed in triplicate. Cell proliferation was monitored
every 24 h using the CASY® Cell Counter and Analyzer
Model TT (Innovatis, Bielefeld, Germany), with cells
>8.03 μm being defined as viable. To test C. reinhardtii ex-
tracts, transformant TN-hGH, and the negative control TN-C,
cells were cultured in 500-ml TAP medium to a concentration
of 2 × 106 cells/ml, broken by three cycles of freezing in liquid
nitrogen and thawing, centrifuged at 9000 g for 30 min,
followed by ultracentrifugation of the supernatant at 100,
000 g for 60 min. The hGH content in the TN-hGH extract
was quantified by Western blotting as above and a volume
containing ~100 ng hGH used in the proliferation assay, to-
gether with an equivalent amount of TN-C extract, or phos-
phate buffer as controls. The experiment was repeated in trip-
licate with proliferation measured after 96 h.
Sequence data The Genbank accession number of the syn-
thetic hGH used in the study is KU179444.
Results
TheΔpsbH strain TN72 for reliable,marker-free selection
of transformant lines
Our previous research has shown that disruption of the chlo-
roplast gene psbH, which encodes the 9 kDa phosphoprotein
subunit of photosystem II, results in a complete destabilization
of this complex. As a result, psbH mutants are blocked in
photosynthetic function and, thus, have an acetate-dependent
phenotype (O’Connor et al. 1998). These mutants can be re-
stored to phototrophy following biolistic transformation with
a plasmid carrying wild-type psbH, with selection on minimal
medium (Bateman and Purton 2000). The psbH gene can
therefore be used as an effective selectable marker for
C. reinhardtii, as has been established for other photosynthetic
genes including atpB, tscA, and rbcL (Boynton et al. 1988;
Goldschmidt-Clermont 1991; Chen and Melis 2013).
However, our original recipient strain “Bst-same”
(O’Connor et al. 1998) contains a cell wall and therefore must
be transformed either using the expensive biolistics method or
by removing the cell wall using autolysin before glass bead-
mediated transformation (Economou et al. 2014). To combine
the benefits of photosynthetic selection and the simple, cheap
glass bead method, a new psbH mutant (TN72) was created
that carries the cw15 nuclear mutation and thus lacks a cell
wall. In addition, we eliminated one other flaw with Bst-same,
which is that psbH is disrupted by insertion of the aadAmark-
er into the coding region while GOIs are targeted to an
intergenic site between trnE2 and psbH that is 0.36 kb down-
stream of the aadA insertion. This means that transformation
can occasionally generate transformants in which psbH is re-
stored (and aadA eliminated), but the GOI is not introduced
because homologous recombination between vector and ge-
nome has occurred in this 0.36 kb region. To solve this, the
TN72 line was constructed such that the whole region is re-
placed by the aadA marker, thereby disrupting psbH and en-
suring that transformants can arise only by integration of both
psbH and the GOI (Fig. 1). Details of the creation of TN72 are
given in Figs. S3 and S4.
New expression vectors allow a perfect fusion of the GOI
to the 5′UTR and rapid establishment of chloroplast
homoplasmy
Translation is a key regulatory step in gene expression in the
C. reinhardtii chloroplast (Eberhard et al. 2002) and typically
involves one or more trans-acting protein factors that bind to
cis elements with the 5′UTR of the transcript and mediate
efficient ribosome binding and translation initiation
(Choquet and Wollman 2002; Specht and Mayfield 2013).
Furthermore, the bases immediately upstream of the start co-
don have been shown to play an important role in efficient
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translation initiation (Esposito et al. 2001). We therefore de-
signed an expression vector that uses the type IIS restriction
enzyme SapI for cloning. As illustrated in Fig. 2, SapI cuts to
give a three-base 5′ overhang to one side of its recognition site.
This allows the joining of a chloroplast promoter/5′UTR ele-
ment to the ATG of a GOI as a perfect fusion without the
incorporation of the site itself, and therefore without the need
to introduce any DNA changes upstream of the start codon or
add additional codons to the start of the GOI.
In order to test different transcription and translation effi-
ciencies, four different versions of the vector were constructed
that each have the samemultiple cloning site for GOI insertion
followed by the 3′UTR from the endogenous rbcL gene, but
differ in the endogenous promoter/5′UTR element used to
drive expression, namely that from psaA exon 1 (vector
pSRSapI), atpA (pASapI), psbA (pPSapI), and chlL
(pCSapI) as detailed in Table S2. Each vector can be used in
combination with the TN72 line to target any GOI to the
neutral locus within the psbH-trnE intergenic region, using
restoration of psbH as selection as illustrated in Fig. 1.
Since the C. reinhardtii plastome is polyploid with ~40
copies per cell under phototrophic conditions and ~100 copies
under mixotrophic conditions (Lau et al. 2000), an important
early step in the analysis of putative transformant lines is to
confirm that the GOI has inserted into the plastome and that all
copies carry the GOI—i.e., the lines are homoplasmic (Purton
2007). We have devised a PCR strategy involving three
a
b
trnE2
MCS
SapI – SphI
pUC8
Pr/5’UTR 3’UTR 
rbcL
psbH
ATG
psbN
2.2 kb0.8 kb
vector                                                 gene of interest
SapI SapI
...CTTTTTT/ATG AGAAGAGC...      ...GCTCTTCT/ATG NNN NNN...
...GAAAAAA TAC/TCTTCTCG...      ...CGAGAAGA TAC/NNN NNN...
ligation
...CTTTTTT ATG NNN NNN ...
...GAAAAAA TAC NNN NNN ...
Fig. 2 Design of expression vectors and SapI cloning scheme. a Four
different vectors were constructed that contained a promoter/5′untranslated
region (Pr/5′UTR) from different chloroplast genes, namely pASapI (atpA),
pSRSapI (psaA-exon 1), pPSapI (psbA), and pCSapI (chlL). b The
positioning of the SapI site in the vector and in any synthetic gene of
interest to allow a perfect fusion at the ATG start codon
trnE2 psbN
aadA
(spcR)
plastome of TN72
(PSII–; spcR)MluI
psbH
transforming 
plasmid
GOI
plastome of TF
(PSII+; spcS)
BstXI
+ acetate
+ Spc100
no acetate
no Spc
+ acetate
+ Spc100
no acetate
no Spc
F1
R1
R2
F1
Fig. 1 Strategy for generation of marker-less transformants using the TN72
recipient. The transforming plasmid contains the gene-of-interest (GOI)
cassette which comprises a chloroplast promoter/5′UTR element from a
chloroplast gene, coding sequence of the GOI and a 3′UTR from a
chloroplast gene. The cassette is flanked by plastome sequence that
includes psbH as selectable marker. Introduction into the chloroplast of
strain TN72 (a knockout strain in which psbH and the downstream region
have been replaced with the aadA marker) results in restoration of psbH,
introduction of the GOI and loss of aadA. As a result, transformants (TF) are
capable of phototrophic growth on acetate-free medium and are sensitive to
spectinomycin (Spc) as shown in the lower panel. Red arrows indicate the
three-primer set used to determine homoplasmy as detailed in Table S1
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primers (indicated in Fig. 1, with details in Table S1) to con-
firm both integration and homoplasmy in a single step.
Primers F1 and R1 generate a 0.88-kb PCR product from the
untransformed TN72 plastome, whereas in the transplastomic
genome, a larger band (e.g., 1.13 kb for pSRSapI
transformants) is generated by primers F1 and R2, with primer
R2 designed to the promoter/5′UTR element used in each
vector and primer F1 outside of the left-hand region of homol-
ogy carried on each vector (thereby preventing amplification
from any free plasmid or plasmid integrated into the nuclear
genome). Heteroplasmic lines containing some untransformed
plastome copies would be expected to give rise to both PCR
products.
Initial transformation experiments using pSRSapI to ex-
press a test GOI (the E. coli ereB gene encoding erythromycin
resistance (Arthur and Courvalin 1986)) revealed that all nine
colonies that were tested contained the transgene (Fig. 3a),
supporting the idea that the use of the TN72 recipient ensures
acquisition of the GOI in all transformants. Furthermore, it
was found that selection based on restoration of phototrophy
very rapidly established homoplasmywithout repeated rounds
of single colony isolation. This is in contrast to that observed
with the commonly used aadA marker for spectinomycin re-
sistance, where several rounds of colony isolation on selective
medium are required to drive the transformants to a
homoplasmic state (Day and Goldschmidt-Clermont 2011).
The ease with which homoplasmy is obtained is probably a
reflection of both the strong selective pressure to restore the
photosynthetic phenotype, and the reduced plastome copy
number in colonies growing on minimal medium rather than
the acetate-containing medium used for aadA selection (Lau
et al. 2000). Growth tests of three of the transformant lines on
plates containing erythromycin confirmed the functional ex-
pression of ereB (Fig. 3b).
The pSRSapI vector allows efficient expression in both
C. reinhardtii and E. coli
To compare the expression levels obtained with the four dif-
ferent vectors, a synthetic gene encoding human growth hor-
mone was designed based on the codon preferences of
C. reinhardtii chloroplast genes and cloned into each vector.
Transformants were generated using TN72, and homoplasmy
was established by PCR as above (Fig. 4a). A representative
clone for each vector was used to assess the level of recombi-
nant hGH in both the C. reinhardtii chloroplast and the E. coli
DH5α used for the cloning. As shown in Fig. 4b, c, Western
blot analysis of cell extracts from the C. reinhardtii and E. coli
transformant lines using anti-hGH antibodies revealed mark-
edly differing levels of hGH for the four different promoter/5′
UTR elements. In the chloroplast, both the psaA and atpA
elements gave detectable levels of hGH, with psaA showing
a higher level as has been reported previously (Michelet et al.
2011). The protein is not detected in the psbA transformant
lines. This is not surprising given that Rasala et al. (2011) have
reported that transgenes linked to the psbA 5′UTR are poorly
expressed due to the process of auto-attenuation of psbA trans-
lation which is mediated via the 5′UTR. Furthermore, Kasai
et al. (2003) have reported that additional cis elements re-
quired for efficient psbA translation are located downstream
of the start codon and are therefore missing in the vector.
There is also no detectable hGH in the chlL transformant lines.
This probably reflects the very low level of chlL expression in
C. reinhardtii, particularly in cells grown in the light (Cahoon
and Timko 2000). Furthermore, work by Cheng et al. (2005)
showed that the product of a transgene (nifH) linked to the
chlL promoter/5′UTR element was detectable only under con-
ditions of anaerobic growth, suggesting that use of the chlL
element to drive transgene expression is applicable only under
such cultivation conditions. The hGH signals were normalized
to the signal obtained using a control antibody raised to the
large subunit of Rubisco and expressed as relative values of
hGH accumulation. The hGH level from the psaA exon 1
element was ~7.6 times higher than from the atpA element
(Fig. 4b). In E. coli, the highest level of expression is obtained
also from the psaA construct, with levels significantly higher
than those from the psbA and chlL elements. The level from
the atpA element was barely detectable (Fig. 4c). The
TN72::ereB transformants
M     1      2      3      4      5      6      7      8      9    TN72
1500
1000
750
bp
1134
880
er
yt
hr
om
yc
in
 (
µg
/m
l)
20
40
50
TN-C     1      6      9
0
a
b
Fig. 3 PCR confirmation of GOI integration and homoplasmy of
pSRSapI-ereB transformants, and demonstration of erythromycin
resistance. a PCR was performed using genomic DNA from
transformants that had been streaked once only on HSM agar after
colony picking. Primers were F1, R1, and R2 (psaA). The presence of a
1134-bp band confirms the successful integration of ereB, whereas the
absence of the 880-bp band that arises from the untransformed copies of
the TN72 plastome indicates that the transformant lines are homoplasmic.
M = DNA ladder of size markers. b Growth of the control transformant
lacking ereB (TN-C) and three representative ereB transformants on TAP
agar plates containing increasing concentrations of erythromycin
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pSRSapI vector therefore represents a useful dual vector, able
to drive transgene expression in both the C. reinhardtii chlo-
roplast and in E. coli.
A functional hGH is produced in the C. reinhardtii
chloroplast
The transgenic line (named TN-hGH) that was generated
using the pSRSapI-hGH construct was characterized further
in order to assess the level of recombinant hGH produced and
to determine whether the protein was functional. Figure 5a
shows a Western blot in which the level of hGH in this line
is compared with known amounts of a commercial sample of
purified recombinant hGH. In order to mitigate against any
signal differences caused by the presence of other proteins in
the crude cell lysate of TN-hGH, the purified hGH was added
to an equivalent crude lysate from a control transformant line
(TN-C) generated using the pSRSapI vector only (Fig. 5a).
Comparison of the level of hGH in the TN-hGH and spiked
TN-C samples indicates that the hGH is present at ~25 μg/ml
in the final TN-hGH lysate. This represents approximately
0.5 mg hGH per liter of C. reinhardtii culture.
To determine whether the hormone is biologically active, a
proliferation assay was carried out using the Nb2-11 rat lym-
phoma cell line. The replication of Nb2-11 cells in suspension
culture is specifically stimulated by lactogenic hormones, and
by hGH which is known to have lactogenic activity (Tanaka
et al. 1980; Bulatov et al. 1996). This was confirmed using the
commercial hGH which showed a dose-dependent effect of
the hormone on the proliferation of the cell line (Fig. S5). This
proliferation was also seen when a cell extract from TN-hGH
containing approximately 100 ng of hGH was added to the
Nb2-11 cells, thereby confirming its biological activity. As
shown in Fig. 5b, an increase in cell number of approximately
eightfold was obtained after 96 h using the TN-hGH extract
when compared to an equivalent extract from the control
strain TN-C, or to buffer only.
Discussion
Currently, the industrial biotechnology sector is almost
exclusively based around the use of heterotrophic plat-
forms (bacteria, yeasts, mammalian, and insect cells) for
the biosynthesis of pharmaceutical proteins, bioactive
metabolites, or other high-value products (Murphy
2012). Nevertheless, the ever-increasing growth of the
global bioeconomy and the need for sustainable alterna-
tives to petrochemical-based products is catalyzing inter-
est in the exploitation of alternative cell factories, includ-
ing photosynthetic microalgae such as C. reinhardtii
(Wijffels et al. 2013). Recent successes in the biosynthe-
sis of recombinant therapeutics in the C. reinhardtii chlo-
roplast have underlined the potential of this alga as a
commercial platform (Rasala and Mayfield 2015), and
highlight the need for further development of new tools
for rapid and reliable strain engineering (Scaife et al.
2015).
The recipient strain and vectors described here provide a
low-cost and simple system for creating a transgenic line
within a few weeks. Transformation of the TN72 strain is
achieved by agitation with glass beads rather than the more
technically complex particle bombardment method, and the
strong selection for restoration of photosynthesis means
M TN72   atpA psaA psbA chlL
1.5–2.0 kb {
0.88 kb
TN72::hGH transformants
25      100     control  atpA psaA psbA chlL
ng hGH E. coli::hGH transformants
α-hGH
a
c
b
α-hGH
α-RbcL
25      100   control  atpA psaA psbA chlL
ng hGH
relative hGH:       0.01     1.00    7.63     0.06      0.01
TN72::hGH transformants
Fig. 4 Analysis of hGH expression under the control of the different
promoter/5′UTR elements. a PCR confirmation of gene integration and
homoplasmy of hGH transformants. Three-primer PCR demonstrating
the homoplasmic integration of hGH expression cassettes into the
C. reinhardtii chloroplast genome. The TN72 cell line was transformed
with plasmids that introduced the hGH into the plastome downstream of
psbH as illustrated in Fig. 1. PCR of genomic DNA using primers F1, R1,
and R3 (hGH.R) give a 0.88-kb product for the TN72 plastome, and a
1.5–2.0-kb product for the transgenic plastomes depending on the size of
the promoter/5′UTR element. The absence of the 0.88-kb band indicates
that the transformant lines are homoplasmic. M = DNA ladder of size
markers. b Western blot analysis of the C. reinhardtii transformants.
Crude protein extracts, equalized according to the optical density of the
cultures, were fractionated by SDS-PAGE and probed with antibodies to
hGH.Control = a TN72 transformant generated using the empty pSRSapI
vector. Pure recombinant hGH was run alongside to aid quantification of
the 22-kDa protein. An identical gel was blotted and probed with
antibodies to the large subunit (RbcL) of the endogenous Rubisco
enzyme as a loading control. Relative band intensities of hGH were
quantified using an Odyssey Infrared Imaging System and scaled to
give 1.000 for the atpA element. c Western blot analysis of the E. coli
transformants. Control = an E. coli transformant generated using the
empty pSRSapI vector
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that stable, homoplasmic lines are obtained without repeat-
ed rounds of selection. Importantly, the system guarantees
that every selected colony contains the GOI since the de-
letion of the essential PSII gene in TN72 prevents sponta-
neous mutation to phototrophic growth, and the deletion of
the genomic region between psbH and the site of GOI in-
sertion ensures that restoration of psbH is always accom-
panied by insertion of the GOI. Our finding that the psaA
promoter/5′UTR gives high levels of expression in the
chloroplast is in agreement with the findings of Michelet
et al. (2011), who reported that the same psaA element gave
higher levels of their two recombinant proteins than ele-
ments from atpA and psbA. This identifies pSRSapI as
the best of our expression vectors. Furthermore, the obser-
vation that the psaA promoter/5′UTR element used in
pSRSapI is able to drive expression in E. coli provides a
useful tool for testing the synthesis and function of the
recombinant protein prior to generation of C. reinhardtii
transformants. We speculate that the difference we see in
E. coli expression levels for the different chloroplast gene
elements is, in part, due to differences in the efficiency of
translation initiation in E. coli. Of the four genes, the psaA
sequence immediately upstream of the translational start
most closely matches the E. coli Shine-Dalgarno consensus
sequence for ribosome binding (Fig. S6). In contrast, a
weaker match is seen for chlL and psbA, and no match is seen
in the atpA 5′UTR. Furthermore, efficient transcription from the
psaA promoter probably also contributes to the overall expres-
sion in E. coli. The 5′ end of the psaA exon 1 mRNA was
determined by Choquet et al. (1988), and Turmel et al. (1995)
predicted that a TATAAT sequence within the psaA exon 1
promoter region corresponded to the –10 element; this exact
consensus sequence is in fact preceded by TGn, correlating to
the consensus extended –10 element that is thought to contrib-
ute to promoter strength (Hook-Barnard and Hinton 2007).
Promoter prediction software, softberry BPROM, indicates a
possible –35 element (TTGTAA) upstream of the –10 element.
These data predict that the psaA exon 1 promoter would
give strong transcription initiation in E. coli. While ex-
pression in E. coli is a desirable feature of pSRSapI, it
can also present problems when cloning genes that are
deleterious to the bacterium. To address this, we have
200 300 400 500 500
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Fig 5 hGH quantification and activity in the TN72::pSRSapI-hGH
transformant line. a Western blot analysis in which a cell extract from
TN72::pSRSapI-hGH (TN-hGH) was compared with a control extract
from TN72::pSRSapI (TN-C) spiked with known amounts of
recombinant hGH. The lower part of the blot was probed with
antibodies to hGH, and the upper part with antibodies to the large
subunit (RbcL) of Rubisco as a loading control. Antibody binding was
detected by ECL. b Determination of hGH activity using an Nb2-11 cell
proliferation assay. Cell extract from the TN-hGH line (containing
~100 ng hGH) and the control line TN-C lacking hGH was added to
serum-starved Nb2-11 cells at 1 × 105 cells/ml and proliferation
determined after 96 h. An equivalent volume of phosphate buffer was
also used as a negative control. Error bars represent one standard
deviation, n = 3
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recently developed a modified version of the vector car-
rying an engineered chloroplast tRNA gene. The cloning
of synthetic genes carrying internal UGA stop codons
results in premature translation termination in E. coli,
but in the chloroplast, the tRNA recognizes the UGA as
a tryptophan codon (Young and Purton 2016).
As a test of our system, we demonstrated the functional
expression of a native bacterial gene (ereB) and of a codon-
optimized synthetic gene encoding human growth hor-
mone (hGH). Recombinant hGH is used to treat growth
hormone deficiency, Turner syndrome, and several other
conditions (Kirk 2012). Glycosylation of hGH is not re-
quired for biological activity, and therefore recombinant
production in prokaryotic expression systems such as
E. coli is preferred (Sockolosky and Szoka 2013). The
hormone has also been expressed successfully in the tobac-
co chloroplast where it was shown to fold correctly,
forming the two disulfide bonds within the 22-kDa mole-
cule (Staub et al. 2000). This is in contrast to expression in
the E. coli cytoplasm where hGH tends to accumulate
within inclusion bodies that require solubilization and
r e f o l d i ng (Socko lo sky and Szoka 2013 ) . The
C. reinhardtii chloroplast also possesses the machinery
for the correct folding of recombinant proteins and the
formation of multiple disulfide bonds (Tran et al. 2013b),
and our finding that hGH is recovered in a soluble and
active form further supports this. However, it should be
noted that previous studies have indicated that the presence
of the disulfide bonds in hGH is not specifically required
for biological activity (Kim et al. 2013). Further improve-
ment in the yield of hGH could be achieved by introducing
into the transgenic line the nuclear mutation raa-L121G.
This mutation blocks the trans-splicing of psaA-exon1
mRNA and has been shown to greatly increase expression
of transgenes fused to the psaA promoter/5′UTR (Michelet
et al. 2011). Additionally, Ferreira-Camargo et al. (2015)
have reported that the inclusion of selenocystamine in the
growth medium improves the accumulation of proteins
containing disulfide bonds and could therefore also in-
crease hGH yield.
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